Nat Methods

Abstract

U54 CA225088/CA/NCI NIH HHSUnited States/U24 CA233243/CA/NCI NIH HHSUnited States/CSBC U54 CA225088/U.S. Department of Health & Human ServicesNIHNational Cancer Institute (NCI)/U2C CA233254/CA/NCI NIH HHSUnited States/U2C CA233238/CA/NCI NIH HHSUnited States/DRQ-03-20/Damon Runyon Cancer Research Foundation (Cancer Research Fund of the Damon Runyon-Walter Winchell Foundation)/U2C CA233280/CA/NCI NIH HHSUnited States/U2C CA233262/CA/NCI NIH HHSUnited States/01ZZ2004/Bundesministerium f\ufcr Bildung und Forschung (Federal Ministry of Education and Research)/U2C CA233284/CA/NCI NIH HHSUnited States/U2C CA233195/CA/NCI NIH HHSUnited States/U2C CA233311/CA/NCI NIH HHSUnited States/U2C CA233291/CA/NCI NIH HHSUnited States/1U24CA233243-01/U.S. Department of Health & Human ServicesNIHNational Cancer Institute (NCI)/OT2 OD026677/OD/NIH HHSUnited States/P2ZHP3_181475/Schweizerischer Nationalfonds zur F\uf6rderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)/OT2 OD026677/CD/ODCDC CDC HHSUnited States/HHSN261201500003I/CA/NCI NIH HHSUnited States/U2C CA233285/CA/NCI NIH HHSUnited States/U2C CA233303/CA/NCI NIH HHSUnited States/2022-04-14T00:00:00Z35277708PMC90091861133